Perigestational high folic acid: impact on offspring's peripheral metabolic response

Ana Tojal1, Catarina Neves1, Hugo Veiga1

  • 1Department of Biomedicine - Unit of Biochemistry, Faculty of Medicine, University of Porto, Al. Prof. Hernâni Monteiro, 4200-319 Porto, Portugal. keating@med.up.pt.

Food & Function
|October 16, 2019
PubMed

Insights

Perigestational high folic acid (HFA) exposure in dams predisposes offspring to metabolic dysfunction. HFA alters adipocyte phenotype and gene expression, increasing obesity and insulin resistance risk in offspring.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Developmental Biology

Background:

  • Perigestational exposure to excess folic acid (HFA) in dams predisposes offspring to metabolic dysfunction, including hyperglycemia and glucose intolerance.
  • This dysfunction manifests in late adulthood, suggesting long-term programming effects.

Purpose of the Study:

  • To characterize adipocyte phenotype and gene expression profiles related to lipid and glucose metabolism in visceral adipose tissue and skeletal muscle of offspring exposed to HFA.
  • To investigate the combined effects of HFA exposure and fructose challenge on metabolic parameters.

Main Methods:

  • Sprague-Dawley dams were fed either a standard (C) or high folic acid (HFA) diet during gestation and lactation.
  • Offspring were fed standard chow (STD) or standard chow with 10% fructose (FRU) from 10 months of age.
  • Adipocyte morphology and gene expression (lipid/glucose metabolism) were analyzed in visceral adipose tissue and skeletal muscle at 13 months.

Main Results:

  • HFA exposure enlarged visceral adipocytes, potentially via lipoprotein lipase upregulation, and tended to downregulate Glut4 in adipose tissue and skeletal muscle.
  • Fructose challenge in HFA-exposed offspring upregulated lipogenesis genes and decreased jejunal proton-coupled folate transporter (Pcft1) expression.
  • Fructose also downregulated jejunal sodium-glucose cotransporter 1 (Sglt1) in control offspring.

Conclusions:

  • Perigestational HFA exposure induces morphologic and genetic alterations in offspring, predisposing them to insulin resistance and long-term metabolic dysfunction.
  • Combined HFA and fructose exposure exacerbates metabolic dysregulation, highlighting the critical role of perigestational nutrition.
  • This study suggests folic acid acts as a potent programmer of metabolic health trajectories.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
668
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
210
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
163
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
36.1K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
673